Abstract
A procedure for the synthesis of L-α-vinylglycine from L-homoserine lactone is described. The route developed is convenient (only one chromatography step is required) and efficient (72% yield; ≥95% optical yield over 4 steps). Key features include the use of acid-labile protecting groups for the amino (Boc) and carboxyl (diphenylmethyl ester) groups, and the use of the phenylselenolate equivalent derived from sodium borohydride and diphenyl diselenide for L-homoserine lactone cleavage.
α-Vinylglycine, the simplest α-vinyl amino acid, occurs naturally in mushrooms.1 This β, γ-unsaturated amino acid is an important mechanism-based inhibitor of a number of pyridoxal-linked enzymes. Five transaminases, including those for L-aspartate, L-alanine, L-serine and D-alanine2–6, have been shown to be inactivated by racemic vinylglycine. In the case of the D-amino acid transaminases, Soper et al.4 noticed that only D-alanine, and not L-alanine, protected against inhibition and so presumed that D-vinylglycine was the actual suicide inhibitor. One decarboxylase, L-cysteine sulfinate decarboxylase, is also known to be irreversibly inactivated by vinylglycine.7
Optically pure vinylglycine is also a versatile chiral building block, as evidenced by the range of synthetic applications for which it has been employed. Rapoport and coworkers used D-vinylglycine as an important building block in the construction of the mitomycin core.8 Crisp and Glink described the synthesis of a number of interesting chain-extended β,γ-unsaturated amino acids via Heck couplings of vinyl and aryl halides and triflates upon suitably protected L-α-vinylglycine derivatives.9 Most recently, Huwe and Blechert reported a clever route to hydroxypyrrolidines that employs a ring-closing olefin metathesis of an N-allyl-L-α-vinylglycinol as the key step.10
A number of syntheses of α-vinylglycine in both racemic11 and enantiomerically enriched form12 have been developed. As part of a program directed at the synthesis of unnatural, α-branched amino acids, we recently described a general procedure for the formal α-vinylation of protected amino acids to produce higher (i.e. bearing a second α-R group in addition to the α-vinyl group) α-vinyl amino acids in racemic form.13 The key steps in our formal vinylation procedure are: (1) alkylation of an amino acid-derived dianion with ethylene oxide as a vinyl cation equivalent to provide the corresponding α-substituted homoserine lactone;13 and (2) chemoselective alkyl cleavage of this γ-lactone through the agency of new non-reducing phenylselenolate equivalent developed in this work.14–16
More recently, we have been investigating asymmetric versions of this methodology to access enantiomerically enriched α-vinyl amino acids.17 The approaches being taken include the use of chiral dianions for the initial alkylation step18 and enzymatic resolution.19 For vinylglycine, however, the simplest and only α-unbranched member of this class, it seemed reasonable that we might be able to intersect our vinylation procedure at step two. Namely, we envisioned phenylselenolate-mediated lactone cleavage as the key operation in the transformation of L-homoserine lactone into L-α-vinylglycine. Two important issues became apparent. (1) A suitable amino protecting group would need to be found that would withstand phenylselenolate anion at elevated temperatures, yet be removable under mild conditions, following unveiling of the β,γ-unsaturated ester functionality. (2) Racemization was seen as a potential problem, particularly in the first two steps from L-homoserine lactone: base-mediated amino group protection, and nucleophilic, phenylselenolate-mediated lactone cleavage. Optical purity would have to be assessed and, if necessary, conditions modified to minimize racemization.
We are pleased to report here that these issues have been addressed and that the general approach envisioned has now been reduced to practice. An important feature of the successful procedure includes the use of Boc protection for the α-amino group and diphenylmethyl ester protection for the α-carboxyl group, both of which may be removed quantitatively, under exceptionally mild conditions, in the final step. Another key element proved to be the choice of an appropriate phenylselenolate equivalent so as to prevent racemization in the lactone cleavage step.
Thus, Boc-protection of L-homoserine lactone proceeds smoothly to yield 1 in 97% yield (Scheme). Lactone 1 is then cleaved with the phenylselenolate equivalent generated from sodium borohydride and diphenyl diselenide.15a,15c,20 Gratifyingly, the Boc-amino protecting group survives these conditions quite well. This is significant as simple methyl carbamates are readily cleaved by sodium phenylselenolate anion.15d The crude carboxylate salt is protonated and treated with diphenyldiazomethane in the workup to give phenylselenide 2 in 83% yield and in ≥ 96% ee.21
Scheme.

On the other hand, use of the phenylselenolate equivalent derived from the reduction of diphenyl diselenide with sodium trimethoxyborohydride here is efficient (72% yield after esterification with diphenyldiazomethane), but results in partial (8-13%) racemization.21 Consonant with previous findings, then, it appears that the NaBH4-derived reagent is best for unhindered lactones,15a,15c,20 whereas the chemoselective (non-reducing) NaHB(OMe)3-derived reagent is of advantage for sterically hindered α-branched lactones (for which racemization is also not an issue).13,14
Ozone-mediated oxidation and pyrolysis of 2 under the previously reported conditions13 provides protected vinylglycine derivative 3. Deprotection then ensues under very mild conditions. Specifically, treatment of 3 with trifluoroacetic acid, containing an equivalent of acetic acid as diphenylmethyl cation scavenger, at room temperature gives L-α-vinylglycine, as its trifluoroacetate salt 4 in 90% yield for the final two steps. The final product is judged to be ≥95% ee, based upon integration of a 1H NMR spectrum of its Mosher amide, methyl ester.23 This synthesis of L-α-vinylglycine from L-homoserine lactone is efficient (72% over 4 steps) and quite convenient (only one chromatography column is required). Since D-homoserine is also available commercially, the methodology described herein also constitutes a formal synthesis of D-α-vinylglycine.
Clear merits of this procedure for the synthesis of L-vinylglycine are its convenience, chemical efficiency and ready reproducibility. From an economic point of view, the procedure is quite acceptable for preparing several grams of vinylglycine [L-Homoserine currently sells for $45/g (Aldrich) and is readily converted into the lactone,24 whereas L-vinylglycine is priced at $330/50 mg (Sigma)], but becomes expensive for large scale work. This is in contrast to the procedure of Afzali-Ardakani and Rapoport12e,f which begins with L-methionine [$27/100 g (Aldrich)], and to those of the Barton12b and Hanessian12c groups which emanate from L-glutamic acid [$6/100 g]. To adapt the procedure described herein to large scale work, one could begin with L-methionine and convert it to L-homoserine, following Baldwin’s “one-pot” procedure (90% yield).25a Alternatively, it has been reported that L-asparagine [$23/100 g (Aldrich)] can be electrochemically reduced to L-homoserine in 71% yield.25b
All experimental procedures, analytical techniques and instruments employed were as previously described.13 For NMR spectra of the final product, sodium 3-(trimethylsilyl)propanesulfonate was employed as an internal capillary reference. Compounds 1-4 yielded satisfactory combustion analyses: C ± 0.25%; H ± 0.25%; N ± 0.15%.
N-(tert-Butoxycarbonyl)-homoserine lactone (1)
To a solution of homoserine lactone, trifluoroacetate salt (2.00 g, 9.29 mmol; readily obtained from L-homoserine)24,26 and NEt3 (1.4 ml, 9.29 mmol) in CH2Cl2 (38 ml) at 0°C was added di-tert-butyl dicarbonate (2.03 g, 9.29 mmol). The reaction mixture was stirred for 12 h at rt and then washed with H2O (1 × 25 ml) and 1N HCl (1 × 25 ml). The organic layer was dried (MgSO4) and evaporated to give 1 (1.82 g, 97%) as a white solid, mp 111-113°C.
[α]D24=+8.16 (c =2.5, CHCl3).
1H NMR (300 MHz, CDCl3): δ = 1.44 (s, 9 H), 2.16-2.25 (app quintet, J = 12 Hz, 1 H), 2.69-2.79 (m, 1 H), 4.18-4.28 (ddd, J = 5, 9, 11 Hz, 1 H), 4.29-4.38 (m, 1 H), 4.40-4.46 (app t, J = 9 Hz, 1 H), 5.03-5.10 (m, 1 H).
13C NMR (75 MHz, CDCl3): δ = 28.1, 30.1, 50.0, 65.6, 80.3, 155.4, 175.4.
IR (ATR): v = 3360 (br),2981, 2931, 1776, 1684 cm−1
Diphenylmethyl N-(tert-butoxycarbonyl)-2-[2′-(phenylseleno)ethyl]glycinate (2)
To an argon-purged flask containing sodium borohydride (310 mg, 8.19 mmol) was added a solution of diphenyl diselenide (1.58 g, 7.45 mmol) in DMF (60 ml), via cannula. To this solution was added, via cannula, a solution of lactone 1 (1.50 g, 7.45 mmol) in DMF (60 ml), and the reaction was heated at 100°C for 1 h. After cooling to 0°C, methanol (15 ml) was added and the crude mixture was stirred 5 h. The solvent was removed in vacuo, and the residue was partitioned between Et2O (200 ml) and 100 mM NaOAc buffer (pH 5). The aqueous layer was extracted twice more with Et2O (200 ml). The combined organics were dried (MgSO4), filtered, and esterified with diphenyldiazomethane27 (1.88 g, 9.69 mmol) in EtOAc. Evaporation of the solvent and chromatography (0-15% EtOAc/hexane) yielded 2 (3.24 g, 83%) as a white solid, mp 108-110°C.
[α]D24= +12.28 (c =2.9, CHCl3).
1H NMR (300 MHz, CDCl3): δ = 1.42 (s, 9 H), 1.96-2.06 (m, 1 H), 2.17-2.25 (m, 1 H), 2.76-2.85 (m, 2 H), 4.53-4.56 (app dd, J = 8, 12 Hz, 1 H), 5.05-5.08 (d, J = 8 Hz, 1 H), 6.86 (s, 1 H), 7.20-7.45 (m, 15 H).
13C NMR (75 MHz, CDCl3): δ = 22.93, 28.24, 33.31, 53.61, 78.05, 80.01, 126.95, 127.07 (2C), 128.0, 128.1, 128.5, 128.6 (2C), 129.1, 133.0, 139.4, 139.5, 155.2, 171.2.
IR (ATR): v = 3370 (br),2981, 1743, 1712 cm−1
Diphenylmethyl N-(tert-butoxycarbonyl)-2-vinylglycinate (3) and α-Vinylglycine, trifluoroacetate salt (4)
Ozone was bubbled into a solution of selenide 2 (474 mg, 0.913 mmol) in CH2Cl2 (10 ml) at −78°C until a light blue color persisted. After addition of 1-hexene (2 ml, 16 mmol), this cold solution was added dropwise to refluxing PhH (36 ml) and refluxing was continued for 1 h. Evaporation gave crude 3 as an oil. If desired, an analytical sample of 3 could be obtained by recrystallization (hexanes): mp 89-91°C.
[α]D24= +10.11 (c =3.5, CHCl3).
1H NMR (300 MHz, CDCl3): δ = 1.45 (s, 9 H), 4.97-5.04 (m, 1 H), 5.19-5.23 (d, J = 7 Hz, 1 H), 5.26-5.29 (d, J = 10 Hz, 1 H), 5.33-5.39 (d, J = 18 Hz, 1 H), 5.89-6.00 (m, 1 H), 6.90 (s, 1 H), 7.25-7.42 (m, 10 H).
13C NMR (75 MHz, CDCl3): δ = 28.19, 55.88, 78.09, 79.98, 117.7, 126.9, 127.1, 127.97, 128.04, 128.2, 128.5, 132.4, 139.39, 139.45, 154.9, 169.71.
IR (ATR): v = 3375 (br),2977, 1743, 1711 cm−1
It was found to be most convenient, however, to deprotect crude 3 without purification. To a solution of crude 3 in CH2Cl2 (18 ml) at 0°C were added CF3COOH (10 ml) and AcOH (57 μl, 1.01 mmol). The reaction mixture was allowed to warm to rt. After 8 h at rt, H2O (30 ml) was added, followed by extraction with CH2Cl2 (3 × 20 ml) and Et2O (3 × 20 ml). Evaporation of the aqueous layer, followed by thorough drying (50°C, 0.5 torr, P2O5 sidearm) yielded 4 (176 mg, 90% for two steps).
[α]D24= +42.81 (c =1.1, H2O).
1H NMR (300 MHz, D2O): δ = 4.52-5.55 (d, J = 7 Hz, 1 H), 5.48-5.50 (d, J = 5 Hz, 1 H), 5.53-5.54 (d, J = 2 Hz, 1 H), 5.87-6.00 (ddd, J = 7, 10, 17 Hz, 1 H).
13C NMR (75 MHz, D2O): δ = 57.69, 119.0 (q, J = 291 Hz), 125.7, 130.6, 165.5 (q, J = 35 Hz), 173.1.
Acknowledgments
Financial support from the National Institutes of Health (CA 62034) is gratefully acknowledged. M. K. S. is the recipient of a Patricia Roberts Harris Fellowship from the U.S. Department of Education (P094B30120).
References
- 1.Dardenne G, Casimir J, Marlier M, Larsen PO. Phytochemistry. 1974;13:1897. [Google Scholar]
- 2.Rando RR, Relyea N, Cheng L. J Biol Chem. 1976;251:3306. [PubMed] [Google Scholar]
- 3.Rando RR. Biochemistry. 1974;13:3859. doi: 10.1021/bi00716a006. [DOI] [PubMed] [Google Scholar]
- 4.Soper TS, Manning JM, Marcotte PA, Walsh CT. J Biol Chem. 1977;252:1571. [PubMed] [Google Scholar]
- 5.Cornell NW, Zuurendonk PF, Kerich MJ, Straight CB. Biochem J. 1984;220:707. doi: 10.1042/bj2200707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cho C, Ishii R, Hyeon S, Suzuki A. Agric Biol Chem. 1987;51:2597. [Google Scholar]
- 7.Griffith OW. J Biol Chem. 1983;258:1591. [PubMed] [Google Scholar]
- 8.Shaw KJ, Luly JR, Rapoport H. J Org Chem. 1985;50:4515. [Google Scholar]
- 9.Crisp GT, Glink PT. Tetrahedron. 1992;48:3441. [Google Scholar]
- 10.Huwe CM, Blechert S. Tetrahedron Lett. 1995;36:1621. [Google Scholar]
- 11.For syntheses of (±)-α-vinylglycine see:; (a) Fitzner JF, Pratt DV, Hopkins PB. Tetrahedron Lett. 1985;26:1959. [Google Scholar]; (b) Vyas DM, Chiang Y, Doyle TW. J Org Chem. 1984;49:2037. [Google Scholar]; (c) Greenlee WJ. J Org Chem. 1984;49:2632. [Google Scholar]; (d) Hudrlik PF, Kulkarni AS. J Am Chem Soc. 1981;103:6251. [Google Scholar]; (e) Baldwin JE, Haber SB, Hoskins C, Kruse LI. J Org Chem. 1977;42:1239. doi: 10.1021/jo00427a031. [DOI] [PubMed] [Google Scholar]; (f) Friis P, Helboe P, Larsen PO. Acta Chem Scand Ser B. 1974;28:317. doi: 10.3891/acta.chem.scand.28b-0317. [DOI] [PubMed] [Google Scholar]
- 12.For enantioselective syntheses of α-vinylglycine, see:; (a) Pellicciari R, Natalini B, Marinozzi Synthetic Commun. 1988;18:1715. [Google Scholar]; (b) Barton DHR, Crich D, Herve Y, Potier P, Thiery J. Tetrahedron. 1985;41:4347. [Google Scholar]; (c) Hanessian S, Sahoo SP. Tetrahedron Lett. 1984;25:1425. [Google Scholar]; (d) Krol WJ, Mao S-S, Steele DL, Townsend CA. J Org Chem. 1991;56:728–731. [Google Scholar]; (e) Schöllkopf U, Nozulak J, Groth U. Tetrahedron. 1984;40:1409. [Google Scholar]; (f) Afzali-Ardakani A, Rapoport H. J Org Chem. 1980;45:4817. [Google Scholar]; (g) Carrasco M, Jones RJ, Kamel S, Rapoport H, Truong T. Org Syn. 1991;70:29. [Google Scholar]
- 13.Pedersen ML, Berkowitz DB. J Org Chem. 1993;58:6966. [Google Scholar]
- 14.Pedersen ML, Berkowitz DB. Tetrahedron Lett. 1992;33:7315. [Google Scholar]
- 15.For pioneering work on the use of phenylselenolate anion to cleave lactones, see:; (a) Scarborough RM, Jr, Smith AB., III Tetrahedron Lett. 1977:4361. [Google Scholar]; (b) Liotta D, Santiesteban H. Tetrahedron Lett. 1977:4369. [Google Scholar]; (c) Scarborough RM, Jr, Toder BH, Smith AB., III J Am Chem Soc. 1980;102:3904. [Google Scholar]; (d) Liotta D, Ustan S, Santiesteben H, Markiewicz W. J Org Chem. 1981;46:2605. [Google Scholar]
- 16.For other phenylselenolate anion equivalents, see:; (a) Hoye TR, Caruso AJ. Tetrahedron Lett. 1978:4611. [Google Scholar]; (b) Dowd P, Kennedy P. Synthetic Commun. 1981;11:935. [Google Scholar]; (c) Ley SV, O’Neill IA, Low CMR. Tetrahedron. 1986;46:5363. [Google Scholar]; (d) Soucy F, Wernic D, Beaulieu P. J Chem Soc Perkin I. 1991;2885 [Google Scholar]
- 17.For previous syntheses of higher α-vinyl amino acids (α-vinylalanine, α-vinylbutyrine and α-vinylphenylalanine) in optically enriched form, see:; (a) Weber T, Aeschimann R, Maetzke T, Seebach D. Helv Chim Acta. 1986;69:1365. [Google Scholar]; (b) Seebach D, Bürger HM, Schickli CP. Liebigs Ann Chim. 1991:669. [Google Scholar]; (c) Colson P-J, Hegedus LS. J Org Chem. 1993;58:5918. [Google Scholar]
- 18.For a related application of chiral dianions to synthesize enantiomerically enriched α-methyl amino acids, see:; Berkowitz DB, Smith MK. J Org Chem. 1995;60:1233. doi: 10.1021/jo00110a029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Berkowitz DB, Pumphrey JA, Shen Q. Tetrahedron Letters. 1994;35:8743. [Google Scholar]
- 20.Berkowitz DB. Synthetic Commun. 1990;20:1819. [Google Scholar]
- 21.Optical purity was judged by the 1H NMR spectra of both (1) a Mosher ester22 [derived from 2 by the sequence: (a) LiBH4, THF; 0-60°C; (b) (S)-(+)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride, DMAP, NEt3, CH2Cl2] and (2) a Mosher amide [obtained by replacing Ph2CN2 with H2CN2 in step 2 and then treatment with: (a) TFA, CH2Cl2; (b) (S)-(+)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride, DMAP, NEt3, CH2Cl2]. In each case, the 1H NMR spectrum thereby obtained was compared to that of the Mosher ester or amide derived from (±)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride.
- 22.Dale JA, Dull DL, Mosher HS. J Org Chem. 1969;34:2543. [Google Scholar]
- 23.To obtain this Mosher amide, the final product was subjected to the following sequence: (a) HCl, MeOH,Δ;12e (b) (S)-(+)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride, DMAP, NEt3, CH2Cl2.22 The 1H NMR spectrum (CDCl3, 500 MHz) of this Mosher amide was compared with that of the diastereomeric Mosher amides obtained by the same sequence, starting from (±)-vinylglycine. The vinylic methine protons, the methyl ether singlets and the methyl ester singlets are resolved in the spectrum of the two diastereomers.
- 24.Lagarias JC, Glazer AN, Rapoport H. J Am Chem Soc. 1979;101:5030. [Google Scholar]
- 25.(a) Baldwin JE, Flinn A. Tetrahedron Lett. 1987;28:3605. [Google Scholar]; (b) Kokusenya Y, Matsuoka M. Denki Kagaku oyobi Kogyo Butsuri Kaguku. 1987;55:174. Chemical Abstracts 1987, 107:134645a. [Google Scholar]
- 26.One may also begin with L-homoserine lactone, which is commercially available as its hydrochloride salt. However, L-homoserine is a more economical starting material.
- 27.(a) Holton TL, Shechter H. J Org Chem. 1995;60:4725. [Google Scholar]; (b) Miller JB. J Org Chem. 1959;24:560. [Google Scholar]
